A r t i c l e s T cells are pivotal in controlling immune responses to fight infection, eradicate tumors and elicit autoimmunity. CD8 + T cells are cytotoxic and mediate the killing of target cells 1 , whereas CD4 + T cells differentiate into various helper T cell subsets, such as T H 1 cells, T H 2 cells, T H 17 cells and regulatory T cells, to modulate the functions of innate cells, B cells and T cells.
For an effective T cell response, a series of events (including the activation, population expansion and differentiation of cells) need to be accomplished after antigenic and mitogenic stimulation. Identifying the factors critical for these processes is a central issue in T cell immunology.
T cell activation by ligation of the T cell antigen receptor (TCR) is followed by T cell proliferation. In addition, T cell proliferation can be further promoted and sustained by cytokines produced by T cells and non-T cells. The TCR and cytokine receptors signal through largely discrete pathways with shared components 2, 3 . Nevertheless, critical factors for the activation and population expansion of T cells remain incompletely identified.
GATA-3 is a transcription factor with high expression in CD4 + T H 2 cells [4] [5] [6] . It is required for the differentiation of T H 2 cells and is therefore regarded as a master regulator for these cells. GATA-3 also regulates T cell development 7, 8 , the generation and function of natural killer cells 9, 10 , the function regulatory T cells [11] [12] [13] and the generation of type 2 innate lymphoid cells 14, 15 , as well as tumorigenesis 16, 17 . Outstanding questions are whether GATA-3 is important for the function of mature T cells beyond T H 2 differentiation and whether a common mechanism can be used by GATA-3 to control the function of different cell types.
To address those questions, we investigated GATA-3 expression in CD8 + T cells. We found that GATA-3 expression was constitutive in CD8 + T cells, was upregulated by activation via the TCR and was further increased by cytokine stimulation. Deletion of GATA-3 in CD8 + T cells did not affect CD8 + thymocyte development, but the long-term peripheral maintenance of GATA-3-deficient CD8 + cells was impaired, with lower expression of the receptor for interleukin 7 (IL-7R; also called CD127) and defective responses to IL-7. The proliferation of CD8 + T cells promoted by the TCR and cytokines was almost completely abolished in the absence of GATA-3. GATA-3-deficient CD8 + T cells failed to expand their populations in response to infection with lymphocytic choriomeningitis virus (LCMV) and during graft-versus-host responses in vivo. Mechanistically, we identified the proto-oncoprotein c-Myc as a critical target of GATA-3 in regulating T cell proliferation. Therefore, our study demonstrates a fundamental role for GATA-3 in T cell function.
RESULTS

GATA-3 expression in CD8 + T cells
To study GATA-3-controlled T cell functions beyond T H 2 differentiation, we investigated GATA-3 expression in CD8 + T cells. We first assessed the expression of GATA-3 in naive CD8 + T cells under steady-state conditions. In contrast to B cells, in which we detected minimal GATA-3 expression, in naive CD8 + T cells we detected substantial GATA-3 protein expression, albeit lower than that of naive CD4 + T cells (Fig. 1a) . Thus, GATA-3 was expressed constitutively in CD8 + T cells. In addition, because activation via the TCR can promote GATA-3 expression in CD4 + single-positive thymocytes 18 , we evaluated the effect of such activation on GATA-3 expression in mature CD8 + T cells. GATA-3 expression was higher after activation via the TCR (Fig. 1b) . We also investigated whether GATA-3 expression in CD8 + T cells was further promoted by stimulation with IL-2 or the T H 2 cytokine IL-4, as it is in CD4 + T cells 4, 12, 19 . Stimulation with IL-4 or IL-2 further enhanced GATA-3 expression in activated CD8 + T cells (Fig. 1c) .
In contrast to T H 2 cells, in which higher GATA-3 expression leads to more IL-4 production 4 , CD8 + T cells did not show an association of the induction of GATA-3 expression with IL-4 expression ( Fig. 1d and Supplementary Fig. 1a) . We recovered significantly more CD8 + T cells, however, after stimulation with IL-2 or IL-4 than without stimulation (Fig. 1e) . The greater abundance of cells was due mainly to enhanced cell proliferation (Fig. 1f) rather than to improved cell survival (Supplementary Fig. 1b) . These findings therefore suggested that GATA-3 was expressed in CD8 + T cells and was further induced by stimulation by the TCR and cytokines.
CD8 + T cell development in the absence of GATA-3 We further investigated the role of GATA-3 in the function of CD8 + T cells. We crossed mice expressing Cre recombinase driven by Cd4 (Cd4-Cre mice) 20 with mice with loxP-flanked Gata3 alleles (Gata3 fl/fl mice) 21 to generate Cd4-Cre-Gata3 fl/fl mice, in which Gata3 is deleted at the CD4 + CD8 + double-positive developmental stage in the thymus. We confirmed efficient deletion of GATA-3 at the level of both protein and mRNA (Figs. 1a and 2a) . In the absence of GATA-3, although the development of CD4 + CD8 -single-positive thymocytes was almost completely abolished, the generation of CD4 -CD8 + single-positive thymocyte was not affected (Fig. 2a) , in agreement with published reports 6, 8, 21 . However, the expression of thymocyte-maturation markers, such as CD5, CD24 and CD69, seemed slightly perturbed in the absence of GATA-3 ( Supplementary Fig. 2a ). There were considerably fewer mature CD4 + T cells in the periphery of Cd4-Cre-Gata3 fl/fl mice than in that of Cd4-Cre-Gata3 fl/+ mice, whereas the number of CD8 + T cells was normal or slightly higher in Cd4-Cre-Gata3 fl/fl mice than in Cd4-Cre-Gata3 fl/+ mice ( Fig. 2a and Supplementary Fig. 2b ).
Cd4-Cre-Gata3 fl/fl CD8 + T cells had an activated phenotype and included a higher percentage of CD62L lo CD44 hi effector T cells than did Cd4-Cre-Gata3 fl/+ CD8 + T cells (Fig. 2b) , and this was associated with more interferon-γ (IFN-γ) production (Fig. 2c) .
Because the lack of CD4 + T cell generation in Cd4-Cre-Gata3 fl/fl mice could have created an aberrant environment for the population expansion and activation of CD8 + T cells 22, 23 , we further investigated the cell-intrinsic effect of deleting GATA-3 in CD8 + T cells. To do so, we generated mixed-bone marrow chimeras by transferring equal numbers of bone marrow cells from Cd4-Cre-Gata3 fl/fl mice and wild-type mice (bearing the congenic markers CD45.2 and CD45.1, respectively) into irradiated recipient mice deficient in recombination-activating gene 1 (Rag1 −/− ). In fully reconstituted mixed-bone marrow chimeras, a similar percentage of Cd4-Cre-Gata3 fl/fl and wild-type CD8 + T cells were generated in the thymus and periphery (Fig. 2d) . In addition, the expression of T cell-maturation markers was similar in Cd4-Cre-Gata3 fl/fl and wild-type CD4 -CD8 + single-positive thymocytes from the same host ( Supplementary  Fig. 2c) . Furthermore, the frequency of activated (CD62L lo CD44 hi ) T cells was similar in Cd4-Cre-Gata3 fl/fl and wild-type CD8 + T cells (Fig. 2e) , with minimal IFN-γ production (Fig. 2f) in the same host. These findings suggested that the perturbed expression of maturation markers in CD4 -CD8 + single-positive thymocytes and the activated phenotype of CD8 + T cells in the periphery of Cd4-Cre-Gata3 fl/fl mice was probably due to extrinsic mechanisms. Therefore, the development of CD8 + T cells was largely unaffected by the deletion of GATA-3. 
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Long-term maintenance of CD8 + T cells requires GATA-3 Cd4-Cre-Gata3 fl/fl CD8 + T cells efficiently populated the periphery of the chimeras described above within 3 months after reconstitution with Cd4-Cre-Gata3 fl/fl and wild-type bone marrow. Starting at 4 months after reconstitution, we noticed a gradual decrease in the number of Cd4-Cre-Gata3 fl/fl CD8 + T cells (data not shown). To determine if the peripheral maintenance of CD8 + T cells was impaired in the absence of GATA-3, we purified naive (CD62L hi CD44 lo ) CD8 + T cells from Cd4-Cre-Gata3 fl/fl (CD45.2 + ) mice and wildtype (CD45.1 + ) mice. We mixed the purified cells at a ratio of 1:1, labeled them with the cytosolic dye CFSE as a tracker for live cells and then transferred them into immunocompetent syngeneic wild-type (CD45.2 + ) mice. Although the maintenance of Cd4-Cre-Gata3 fl/fl CD8 + cells was similar to that of their wild-type counterparts during the first 2 weeks, we recovered almost no Cd4-Cre-Gata3 fl/fl CD8 + T cells at 4 weeks after transfer (Fig. 3a) , which suggested that the long-term peripheral maintenance of CD8 + T cells was defective in the absence of GATA-3.
To determine whether CD8 + T cells isolated from Cd4-Cre-Gata3 fl/fl mice experienced developmental and homeostatic abnormalities ( Fig. 2) that may have contributed to the defective maintenance of these cells in the recipient mice, we further investigated GATA-3 function in mature CD8 + T cells. To do so, we generated ER-CreGata3 fl/fl mice by crossing mice expressing Cre from an estrogen receptor-dependent cassette (ER-Cre mice) 24 with Gata3 fl/fl mice. In cells that express the ER-Cre cassette, Cre recombinase is not active until an agonist of the estrogen receptor, such as tamoxifen or 4-hydroxy-tamoxifen, is provided. Therefore, T cells in ER-CreGata3 fl/fl mice are functionally equivalent to those of wild-type mice before such agonist treatment. We used this system to time the deletion of GATA-3 in mature T cells. We sorted naive CD8 + T cells from ER-Cre-Gata3 fl/fl (CD45.2 + ) mice and wild-type (CD45.1 + ) mice, mixed the cells at a ratio of 1:1, labeled them with CFSE and then transferred them into immunocompetent syngeneic wild-type (CD45.2 + ) mice. We mock-treated one group of recipient mice with vehicle (corn oil) and treated the other group with tamoxifen to induce deletion of Gata3 in the transferred cells in vivo (Fig. 3b) .
We found that ER-Cre-Gata3 fl/fl CD8 + T cells were almost completely absent by 4 weeks after transfer in tamoxifen-treated mice but not in mock-treated mice (Fig. 3b) . These findings suggested a requirement for GATA-3 in the peripheral maintenance of CD8 + T cells. IL-7 is crucial for the maintenance of T cells in the periphery 25 . We found that expression of IL-7R (CD127) was much lower in Cd4-Cre-Gata3 fl/fl CD8 + T cells than in their wild-type counterparts (Fig. 3c,d ). In addition, Cd4-Cre-Gata3 fl/fl CD8 + T cells were defective in responding to IL-7-promoted survival in vitro relative to the response of wild-type CD8 + T cells (Fig. 3e) . We further investigated whether GATA-3 regulates IL-7R expression by binding to the Il7r locus. Through the use of PROMO, a program for the prediction of transcription factor-binding sites, we identified multiple putative GATA-3-binding sites in the Il7r locus. To identify which putative sites bind to GATA-3, we did chromatin-immunoprecipitation (ChIP) assays of sorted primary CD8 + T cells. As a positive control, we detected enrichment for the binding of GATA-3 to the conserved GATA-3-response element 26 in the locus encoding T H 2 cytokines (the 'T H 2 locus') in sorted primary CD8 + T cells (Fig. 3f) .
GATA-3 bound to a conserved regulatory region of Il7r locus (Fig. 3f) , which suggested that GATA-3 controlled IL-7R expression directly in CD8 + T cells. These findings therefore suggested that GATA-3 was required for the long-term peripheral maintenance of CD8 + T cells, at least in part through controlling IL-7R expression and responses to IL-7.
The function of activated CD8 + T cells requires GATA-3 Because GATA-3 expression was promoted by stimulation via the TCR and cytokines, we examined TCR-and cytokine-induced CD8 + T cell function in GATA-3-deficient cells. We sorted naive (CD62L hi CD44 lo ) CD8 + T cells from Cd4-Cre-Gata3 fl/fl (CD45.2 + ) mice and wild-type (CD45.1 + ) mice, mixed the cells and labeled them with CFSE. We then activated the labeled cells in the presence or absence of the cytokines IL-2, IL-4 or IL-15. After TCR ligation, although expression of the T cell-activation marker CD69 was efficiently upregulated in Cd4-Cre-Gata3 fl/fl T cells, upregulation of the expression of CD44 and CD25 was less efficient in Cd4-Cre-Gata3 fl/fl T cells than in wild-type T cells (Fig. 4a) . The TCR-and cytokinepromoted proliferation of T cells was abolished in the absence of A r t i c l e s GATA-3 (Fig. 4b) . Deletion of GATA-3 did not substantially affect the survival of activated T cells (Supplementary Fig. 3a) , whereas the production of IFN-γ by activated CD8 + T cells was affected only slightly by deletion of GATA-3 (Fig. 4c) .
To further study GATA-3 function in activated mature CD8 + T cells, we used CD8 + T cells purified from ER-Cre-Gata3 fl/fl mice, which allowed 'acute' deletion of GATA-3 in mature T cells. We sorted naive CD8 + T cells from ER-Cre-Gata3 fl/fl mice (CD45.2 + ) mice and wild-type mice (CD45.1 + ), mixed them at the ratio of 1:1 and then labeled them with CFSE. We activated the labeled cells in the presence or absence of IL-2, IL-4 or IL-15 and added 4-hydroxytamoxifen to the culture to delete Gata3 fl/fl alleles. The GATA-3-deficient CD8 + T cells upregulated expression of activation markers as efficiently as did their wild-type counterparts (Fig. 4d) , probably because the upregulation of the exppression of these markers occurred quickly after TCR signaling and preceded the functional deletion of GATA-3 in ER-Cre-Gata3 fl/fl T cells. Nonetheless, GATA-3-deficient CD8 + T cells proliferated poorly in response to stimulation via the TCR and cytokines (Fig. 4e) . Deletion of GATA-3 did not lead to obvious change in T cell survival ( Supplementary  Fig. 3b ) but resulted in slightly less IFN-γ production by activated CD8 + T cells (Fig. 4f) . These findings therefore suggested that GATA-3 was critical for CD8 + T cell proliferation in response to stimulation via the TCR and cytokines.
GATA-3 and the proliferation of CD8 + T cells in vivo
To address the requirement for GATA-3 in CD8 + T cell function in vivo, we used a lymphocytic model of infection with LCMV in which the population expansion of LCMV-specific CD8 + T cells can be detected by staining of CD8 + T cells with a tetramer specific for the LCMV epitope of glycoprotein amino acids 33-41 (gp33) 27 . We isolated splenocytes from young wild-type (CD45.1 + ) mice and Cd4-Cre-Gata3 fl/fl (CD45.2 + ) mice, mixed the cells at the ratio of 1:1 and then transferred them into syngeneic (CD45.1 + CD45.2 + ) wildtype recipient mice, then infected the recipients with the Amstrong strain of LCMV. At 8 d after infection, we detected CD8 + T cells reactive to gp33 by tetramer staining. Although gp33-specific wildtype donor CD8 + T cells were readily detectable after infection with LCMV, we found very few gp33-specific Cd4-Cre-Gata3 fl/fl donor CD8 + T cells (Fig. 5a) . In the same experiments, the frequency of IFN-γ-producing gp33-specific CD8 + T cells was much lower among Cd4-Cre-Gata3 fl/fl donor CD8 + T cells than among their wild-type counterparts (Fig. 5b) . Therefore, GATA-3 was required for the population expansion of CD8 + T cells in response to stimulation with a specific viral antigen during LCMV infection. We also investigated the population expansion of GATA-3-deficient CD8 + T cells in an acute graft-versus-host response model, in which transferred CD8 + T cells reacting to major histocompatibility complex-mismatched host cells are activated and their populations are expanded 28, 29 . We isolated splenocytes from ER-Cre-Gata3 fl/fl (CD45.2 + ) mice and wild-type (CD45.1 + ) mice, both on a C57BL/6 background, then mixed the cells at a ratio of 1:1 and transferred into immunodeficient recipient mice (deficient in recombinationactivating gene 2 (Rag2 -/-) and the common γ-chain (Il2rg -/-)) on an allogeneic BALB/c background. Immediately after transfer, we treated recipient mice with tamoxifen for deletion of the Gata3 fl/fl alleles in the transferred cells or mock-treated them with vehicle. We monitored CD8 + T cells of the different donor origins for 3-4 weeks after transfer. In mock-treated recipient mice, the frequency of CD8 + T cells that originated from ER-Cre-Gata3 fl/fl mice and from wildtype mice was similar, whereas in tamoxifen-treated recipient mice, the frequency of ER-Cre-Gata3 fl/fl donor CD8 + T cells was much lower than that of wild-type donor CD8 + T cells (Fig. 5c) .
The defects observed in GATA-3-deficient CD8 + T cells in that setting could have been partly due to failed lymphopenia-driven proliferation 29 , because GATA-3-deficient CD8 + T cells have diminished responses to IL-7. To minimize the effects of lymphopenia-driven proliferation, we treated recipient mice with tamoxifen 2 weeks after cell transfer to allow efficient reconstitution of T cells before deletion of Gata3 fl/fl . Whereas mock-treated mice had a similar abundance of ER-Cre-Gata3 fl/fl and wild-type donor CD8 + T cells, tamoxifentreated mice had considerably fewer ER-Cre-Gata3 fl/fl donor CD8 + T cells than wild-type donor CD8 + T cells (Fig. 5d) . In addition, GATA-3-deficient CD8 + T cells had lower expression of Ki67, an indicator of cell proliferation, than did wild-type CD8 + T cells (Fig. 5e) . Collectively, these findings suggested that GATA-3 was critical for the population expansion of CD8 + T cells under both infectious and inflammatory conditions.
GATA-3 controls c-Myc expression
To gain insight into the mechanisms by which GATA-3 controls the activation and proliferation of CD8 + T cells, we investigated which signaling pathways for the activation and proliferation of T cells were affected by deletion of GATA-3. Activation of pathways of the transcription factor NF-κB and the kinases Jnk and Erk was normal in the absence of GATA-3 (Supplementary Fig. 4a) . Nevertheless, we consistently observed that activated Cd4-Cre-Gata3 fl/fl CD8 + T cells were much smaller than GATA-3-sufficient cells (Fig. 6a) . Because c-Myc is critical for the metabolism, growth and proliferation of T cells 30 
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A r t i c l e s GATA-3 resulted in no upregulation of c-Myc expression (Fig. 6b) . In addition, whereas expression of p27 Kip1 (an inhibitor of cyclin-dependent kinase) was downregulated in wild-type cells at the time of entry into the cell cycle, p27 Kip1 expression remained high in GATA-3-deficient T cells (Supplementary Fig. 4b) , consistent with the observation that T cell proliferation was defective in the absence of GATA-3.
To investigate if c-Myc is a critical functional target of GATA-3 in CD8 + T cells, we assessed whether ectopic expression of c-Myc in GATA-3-deficient T cells ameliorated the proliferation defects. We transduced wild-type and Cd4-Cre-Gata3 fl/fl CD8 + T cells with either control retrovirus or c-Myc-expressing retrovirus (Fig. 6b) and assessed the proliferation of transduced T cells. Whereas Cd4-Cre-Gata3 fl/fl T cells transduced with control virus did not proliferate as well as wildtype T cells transduced with control virus, c-Myc expression considerably enhanced the proliferation of Cd4-Cre-Gata3 fl/fl T cells (Fig. 6c) . Therefore, c-Myc was a downstream target of GATA-3 in the control of T cell proliferation. Through the use of PROMO we identified multiple putative GATA-3-binding sites in the Myc locus. To identify which putative sites bind GATA-3, we did ChIP assays of purified CD8 + T cells. As a positive control for this ChIP assay, we detected enrichment for the binding of GATA-3 to the conserved GATA-3-response element 26 in the T H 2 locus in purified CD8 + T cells (Fig. 6d) . GATA-3 bound to at least two conserved nucleotide sequence in the Myc locus in CD8 + T cells (Fig. 6d) . These findings collectively indicated that GATA-3 controlled T cell function by controlling c-Myc expression. DISCUSSION CD8 + T cells are central in mediating the immune response to clear pathogens, eradicate tumors and elicit inflammation 1 . The normal generation, maintenance and function of CD8 + T cells is needed to achieve effective immune response. Therefore, the identification of factors that control CD8 + T cell function is important for understanding immunoregulation and for treating immunological diseases. Our study has shown that GATA-3, a well-studied factor that controls the T H 2 differentiation of CD4 + T cells 4 , was required for the maintenance and function of CD8 + T cells.
We found that the long-term peripheral maintenance of CD8 + T cells was defective after deletion GATA-3. Such a defect could be attributed to lower IL-7R expression and impaired responses to IL-7. However, the defects of Cd4-Cre-Gata3 fl/fl mice were less severe than those of IL-7R-deficient mice 32 . That suggests that other factors, such as the transcription factor Foxo1 (refs. 33,34) , may compensate for the loss of GATA-3 to promote IL-7R expression in GATA-3-deficient T cells.
Apart from being essential for the peripheral maintenance of CD8 + T cells, IL-7 signaling is required for the development of CD8 + thymocytes 32 . We found that CD8 + T cells developed normally in the absence of GATA-3, which suggested that GATA-3 controls the response to IL-7 in a cell type-specific manner: it is important for the response to IL-7 in mature CD8 + T cells but not in thymocytes. That may contribute to the observation that although the long-term peripheral maintenance of GATA-3-deficient CD8 + T cells was impaired, Cd4-Cre-Gata3 fl/fl mice did not have fewer peripheral CD8 + T cells because they were efficiently generated from the thymus in these mice. Cd4-Cre-Gata3 fl/fl mice could thus serve as a model in which IL-7 signaling is defective in peripheral naive CD8 + T cells without the complications associated with profound developmental defects in CD8 + T cells.
In addition to controlling the development and peripheral maintenance of T cells, IL-7 signaling regulates the differentiation of 37 ) are important for these biological processes. In this study, we found that GATA-3 was required for CD8 + T cells to grow and to proliferate in response to activation and that c-Myc was an important functional target of GATA-3 in promoting the proliferation of CD8 + T cells. Nonetheless, c-Myc may not be the sole downstream target of GATA-3 in controlling such proliferation, because ectopic expression of c-Myc did not fully restore the proliferation of GATA-3-deficient CD8 + T cells. In agreement with that observation, it is reported that GATA-3 regulates N-Myc expression 38 , and we have found deregulated expression of TOB1 and KLF2 in GATA-3-deficient CD8 + T cells (data not shown). Determining how such factors contribute to GATA-3-controlled proliferation of T cells and how they are functionally related to c-Myc will require further study.
We found that GATA-3-deficient CD8 + T cells failed to grow after activation. The abolition of c-Myc expression in these cells may have contributed to this because c-Myc is essential for the metabolism and growth of T cells 30, 31 . Nonetheless, it remains to be determined whether GATA-3-controlled T cell growth, similar to GATA-3-controlled T cell proliferation, is dependent on c-Myc.
Whereas the growth and proliferation of CD8 + T cells required GATA-3, deletion of GATA-3 had a minimal effect on the IFN-γ production of activated CD8 + T cells, which suggested that GATA-3, although essential for the population expansion of CD8 + T cells, is dispensable for the effector functions of CD8 + T cells. Nonetheless, further investigation is needed to address whether GATA-3 is needed for the effector functions of CD8 + T cells, such as the production of granzyme and perforin and cytotoxic T lymphocyte activity. In addition, the finding that deletion of GATA-3 did not result in more IFN-γ production in CD8 + T cells suggested that unlike its effect in CD4 + T cells 39 , GATA-3 does not suppress IFN-γ production in CD8 + T cells. That is in agreemeent with the observation that although stimulation with IL-2 or IL-4 promoted GATA-3 expression, it did not lead to less IFN-γ production by CD8 + T cells.
The function of CD8 + T cells is influenced by the microenvironment and cytokine milieu. We found that GATA-3 controlled CD8 + T cell function, which suggested that factors that enhance GATA-3 expression, such as IL-4, Wnt-TCF-β-catenin 40 and Notch-RBPjκ 21, 41 , may regulate the function of CD8 + T cells. Indeed, those signaling pathways are important for CD8 + T cell function during immune responses [42] [43] [44] . Therefore, it would be useful to determine if and how GATA-3 is involved in IL-4-, Wnt-and Notch-mediated effects on CD8 + T cells during such immune responses.
We have shown that GATA-3, acting through c-Myc, was essential for CD8 + T cell proliferation. However, GATA-3-controlled proliferation may not be limited to CD8 + T cells. Inhibition of GATA-3 leads to less proliferation of T H 2 cells and hematopoietic stem cells 4, 45 , although the underlying mechanism for this remains unclear. Such observations suggest that controlling proliferation is a conserved function of GATA-3 in various cell types of the immune system. Therefore, such a GATA-3 function needs to be taken into consideration in evaluating how immunological function, beyond T H 2 responses, is affected after interference with GATA-3 by genetic or biochemical approaches 5, [46] [47] [48] .
Despite intense interest in the function of GATA-3 in T cells, its involvement beyond T H 2 differentiation is poorly defined. Our study has identified previously unappreciated GATA-3-IL-7R and GATA-3-c-Myc signaling axes fundamental for T cell function and has demonstrated that GATA-3 is critical for the maintenance and proliferation of T cells. In addition, it has shed new light on the mechanism through which T cell function and immune response are controlled.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
